VEGF-C Polyclonal Antibody bs-1586R from Bioss Inc.

Product Specs
ItemVEGF-C Polyclonal Antibody
CompanyBioss Inc.
Price $375.00Supplier Page View Company Product Page
Catalog Numberbs-1586R
Molecular Weight13kDa
ImmunogenKLH conjugated peptide, mouse VEGF-C
Format0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol
Antibody TypePrimary Antibody
IsotypeIgG
Quantity100ul, 20uL
Conjugate/TagUnconjugated
ApplicationsIHC, WB, ELISA, FCM, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), IHC-P, WB
ClonalityPolyclonal
ReactivityHuman, Mouse, Rat, Mouse, Human
HostRabbit
TargetVEGF-C
Concentration1ug/ul
NCBI Gene AliasesVEGF-C
NCBI Full Gene Namevascular endothelial growth factor C
Tissuemouse mammary tissue

Questions and Answers

Can this antibody be used to study VEGF-C expression in cancer tissues?

Yes, the VEGF-C Polyclonal Antibody has been utilized in studies assessing its expression in various cancer tissues, including cutaneous squamous cell carcinoma. Research has shown that increased VEGF-C expression correlates with tumor progression and disease-free survival, indicating its relevance in cancer studies ().

Is this antibody effective for immunofluorescence applications?

The VEGF-C Polyclonal Antibody has been successfully employed in immunofluorescence assays, as demonstrated in studies investigating lymphatic vasculature and inflammatory conditions. It was used at a dilution of 1:100 for detecting VEGF-C in human tissues (; ).

What species can this antibody react with, and is it suitable for human studies?

This antibody is reactive with multiple species, including humans, mice, and rats. Its application in human studies has been documented, particularly in the context of primary Sjögren's syndrome and prostate cancer, highlighting its utility in human tissue analysis (; ).

Are there any specific conditions or diseases where VEGF-C expression has been linked to its role?

Yes, VEGF-C expression has been associated with various conditions, including primary Sjögren's syndrome, where it plays a role in lymphatic neovascularization, and prostate cancer, where its expression is linked to lymphatic metastasis and tumor progression (; ).

Bioss Inc.

300 Tradecenter Drive

Suite 4610

Woburn, MA 01801

United States

Phone: 800.501.7654 (Toll free)
Phone: +1.781.569.5821 (International)

Email: info@biossusa.com
orders@biossusa.com
support@biossusa.com
sales@biossusa.com

Company Profile

Website: www.biossusa.com

(1) The influence of CXCL9 on M2 macrophages in lung cancer developmentTranslational Cancer ResearchDecember 31, 2025Lin Mi, Liyun Xu, Zhijun Chen, Yeye ZhengWaltham, MA, USA). Antibody reagents comprised rabbit-derived polyclonal antibodies targeting VEGF-C (bs-1586R), MMP2/9 (bs-0412R, bs-4593R), ERK/p-ERK (bs-1020R, bs2469R), AKT/p-AKT (bs-0115R and bs-0876R), and

(2) VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell CarcinomaInternational Journal of Molecular SciencesDecember 27, 2023Omar García-Pérez, Leticia Melgar-Vilaplana, Inés Sifaoui, Aleksandra Śmietańska, Elizabeth Córdoba-Lanús, Ricardo Fernández-de-Misaroom temperature (RT). Slides were then incubated with 1:200 diluted polyclonal rabbit VEGFC antibody (bs-1586R, Bioss Antibodies, ThermoFisher Inc., Waltham, MA, USA) for the assessment of VEGFC expression. These

(3) The Impact of Goreisan Components on Rat Mesenteric Collecting Lymphatic Vessel PumpingMicrocirculationApril 1, 2023Michiko Jo, Andrea N. Trujillo, Naotoshi Shibahara, Jerome W. Breslinprimary antibodies used in this study were: rabbit anti-VEGF-C (Bioss Antibodies Inc., Woburn, MA, cat# bs-1586R, 1:1000); rabbit anti-VEGF-C (Bioss cat# bs-1083R, 1:1000); rabbit anti-Prox1 (Abcam, Boston, MA, cat#

(4) Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancerAsian Journal of AndrologyJanuary 1, 2022Xian-Zi Zhou, Jin-Ming Huang, Hong-Peng Zeng, Zhan-Sen Huang, Hong-Peng Huang, Jie-Ying Zhuang, Qun-Xiong Huang, Jin-Ming Zhuangantibody (1:200, ab37154, Abcam, Cambridge, MA, USA) or an anti-VEGF-C rabbit polyclonal antibody (1:300, bs-1586R, BIOSS Antibodies, Beijing, China) at 4°C overnight, the sections were incubated with a biotin-labeled

(5) Expression of Biomarkers (CD44, COX-2, TWIST, VEGF-C and LOX) in Esophageal Cancer: Implication for Prophylactic Radiation FieldInternational Journal of Clinical Oncology and Cancer ResearchJanuary 1, 2021Yasuhito Hagiwara, Kenji Nemoto, Ibuki Ota, Masayoshi Yamada, Osamu Hachiya, Mitsunori YamakawaTWIST (sc-15393, Santa Cruz; Texas, United States), anti-human mouse monoclonal antibody to VEGF-C (BS-1586R, Bioss; Massachusetts, United States) and anti-human rabbit polyclonal antibody to LOX (NB110-41568,

(6) Vascular endothelial growth factor C treatment for mouse hind limb lymphatic revascularizationVeterinary medicine and scienceMay 1, 2019Ferrão JSP, Bonfim Neto AP, da Fonseca VU, Sousa LMMC, Papa PC.animals studied, as described previously (Ramos‐Vara 2011). Primary antibodies used were anti‐VEGFC (bs‐1586R, Bioss Inc., Woburn, MA, USA) and anti‐VEGFR3 (E‐3, sc‐514825, Santa Cruz Biotechnology, Inc., California,

(7) Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndromeJournal of cellular and molecular medicineApril 1, 2016Alunno A, Ibba-Manneschi L, Bistoni O, Rosa I, Caterbi S, Gerli R, Manetti M.ab28364; Abcam, Cambridge, UK), rabbit polyclonal anti‐human VEGF‐C (1:100 dilution; catalogue number bs‐1586R; BIOSS Antibodies, Woburn, MA, USA), rabbit polyclonal anti‐human VEGFR‐3/Flt4 (1:50 dilution; catalogue

(8) Expression of vascular endothelial growth factor-C (VEGF-C) and its receptor (VEGFR-3) in the glial reaction elicited by human mesenchymal stem cell engraftment in the normal rat brainThe journal of histochemistry and cytochemistry : official journal of the Histochemistry SocietyMarch 1, 2015Shin YJ, Riew TR, Park JH, Pak HJ, Lee MY.

(9) The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesisClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 1, 2012Zhuo W, Jia L, Song N, Lu XA, Ding Y, Wang X, Song X, Fu Y, Luo Y.

Be the First to Write a Review!

VEGF-C Polyclonal Antibody

VEGF-C Polyclonal Antibody from Bioss Inc.

Description

Questions and Answers

Bioss Inc.

Citations (9)

Reviews

VEGF-C Polyclonal Antibody from Bioss Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map